Centiva Capital, LP Boston Scientific Corp Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Centiva Capital, LP holds 15,004 shares of BSX stock, worth $1.35 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,004

Previous 19,540 23.21%

Holding current value

$1.35 Million

Previous $1.5 Million 16.42%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$72.96 - $84.0 $330,946 - $381,024	-4,536 Reduced 23.21%	15,004 $1.26 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $1.32 Million - $1.52 Million	19,540 New	19,540 $1.5 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $180,648 - $214,706	3,714 Added 180.38%	5,773 $333,000
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $1.44 Million - $1.57 Million	-28,726 Reduced 93.31%	2,059 $108,000
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $1.4 Million - $1.54 Million	28,114 Added 1052.56%	30,785 $1.67 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $723,198 - $802,431	-16,039 Reduced 85.72%	2,671 $133,000
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $740,167 - $883,486	18,710 New	18,710 $865,000
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $373,015 - $498,553	10,585 New	10,585 $395,000
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $1.61 Million - $1.79 Million	-38,999 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $1.5 Million - $1.73 Million	38,999 New	38,999 $1.67 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $2.04 Million - $2.45 Million	-53,995 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.31 - $43.45 $2.18 Million - $2.35 Million	53,995 New	53,995 $2.2 Million

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Boston Scientific Corp Transaction History